Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
(-)Biological Unit 3
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)
Image Biological Unit 3
Biological Unit 3  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF NK2 IN COMPLEX WITH FRACTIONATED HEPARIN DP10
 
Authors :  R. Recacha, B. Mulloy, E. Gherardi
Date :  01 Jul 11  (Deposition) - 04 Jul 12  (Release) - 04 Jul 12  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.86
Chains :  Asym. Unit :  A,B
Biol. Unit 1:  A,B  (1x)
Biol. Unit 2:  A  (1x)
Biol. Unit 3:  B  (1x)
Keywords :  Kringle Domain, Met Tyrosine Kinase, Hormone (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  R. Recacha, B. Mulloy, E. Gherardi
Crystal Structure Of Nk2 In Complex With Fractionated Heparin Dp10
To Be Published
PubMed: search
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - HEPATOCYTE GROWTH FACTOR ALPHA CHAIN
    ChainsA, B
    EngineeredYES
    Expression SystemPICHIA PASTORIS
    Expression System Taxid4922
    FragmentNK2
    GeneHGF, HPTA
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymHEPATOPOEITIN-A, SCATTER FACTOR, SF

 Structural Features

(-) Chains, Units

  12
Asymmetric Unit AB
Biological Unit 1 (1x)AB
Biological Unit 2 (1x)A 
Biological Unit 3 (1x) B

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (4, 19)

Asymmetric Unit (4, 19)
No.NameCountTypeFull Name
1MES4Ligand/Ion2-(N-MORPHOLINO)-ETHANESULFONIC ACID
2MPD1Ligand/Ion(4S)-2-METHYL-2,4-PENTANEDIOL
3MRD4Ligand/Ion(4R)-2-METHYLPENTANE-2,4-DIOL
4SO410Ligand/IonSULFATE ION
Biological Unit 1 (4, 19)
No.NameCountTypeFull Name
1MES4Ligand/Ion2-(N-MORPHOLINO)-ETHANESULFONIC ACID
2MPD1Ligand/Ion(4S)-2-METHYL-2,4-PENTANEDIOL
3MRD4Ligand/Ion(4R)-2-METHYLPENTANE-2,4-DIOL
4SO410Ligand/IonSULFATE ION
Biological Unit 2 (4, 12)
No.NameCountTypeFull Name
1MES2Ligand/Ion2-(N-MORPHOLINO)-ETHANESULFONIC ACID
2MPD1Ligand/Ion(4S)-2-METHYL-2,4-PENTANEDIOL
3MRD3Ligand/Ion(4R)-2-METHYLPENTANE-2,4-DIOL
4SO46Ligand/IonSULFATE ION
Biological Unit 3 (3, 7)
No.NameCountTypeFull Name
1MES2Ligand/Ion2-(N-MORPHOLINO)-ETHANESULFONIC ACID
2MPD-1Ligand/Ion(4S)-2-METHYL-2,4-PENTANEDIOL
3MRD1Ligand/Ion(4R)-2-METHYLPENTANE-2,4-DIOL
4SO44Ligand/IonSULFATE ION

(-) Sites  (18, 18)

Asymmetric Unit (18, 18)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREARG A:220 , HOH A:371BINDING SITE FOR RESIDUE MRD A 1203
02AC2SOFTWAREASP A:264 , GLN A:266 , TRP A:270 , TYR A:272 , ARG A:279 , TRP A:280 , HOH A:321BINDING SITE FOR RESIDUE MES A 1202
03AC3SOFTWAREGLU A:183 , TRP A:188 , PHE A:190 , ARG A:197 , TYR A:198 , HOH A:387 , HOH A:388 , SER B:161 , HOH B:345BINDING SITE FOR RESIDUE MES A 1201
04AC4SOFTWARETHR A:48 , GLU A:111 , PHE A:112 , HOH A:330 , THR B:48 , GLU B:111 , PHE B:112BINDING SITE FOR RESIDUE MRD A 1207
05AC5SOFTWAREPHE A:112BINDING SITE FOR RESIDUE MRD A 290
06AC6SOFTWARETHR A:49 , LEU A:50 , LEU A:97 , GLU A:227BINDING SITE FOR RESIDUE MPD A 1209
07AC7SOFTWARELYS A:62 , VAL A:64 , ARG A:73 , ARG A:76 , TRP A:98BINDING SITE FOR RESIDUE SO4 A 1
08AC8SOFTWARELYS A:62 , LYS A:63BINDING SITE FOR RESIDUE SO4 A 2
09AC9SOFTWARELYS A:62 , ARG A:73BINDING SITE FOR RESIDUE SO4 A 3
10BC1SOFTWAREARG A:134BINDING SITE FOR RESIDUE SO4 A 5
11BC2SOFTWAREARG A:134 , SER A:135 , HOH A:291BINDING SITE FOR RESIDUE SO4 A 6
12BC3SOFTWARETHR B:49 , LEU B:50 , LEU B:97 , PHE B:116 , HOH B:402BINDING SITE FOR RESIDUE MRD B 1209
13BC4SOFTWAREASP B:264 , GLN B:266 , TRP B:270 , TYR B:272 , ARG B:279 , TRP B:280 , HOH B:410 , HOH B:448BINDING SITE FOR RESIDUE MES B 1202
14BC5SOFTWARESER A:161 , HOH A:388 , GLU B:183 , TRP B:188 , PHE B:190 , ARG B:197 , TYR B:198 , HOH B:298 , HOH B:345BINDING SITE FOR RESIDUE MES B 1201
15BC6SOFTWAREVAL B:64 , ARG B:73 , TRP B:98BINDING SITE FOR RESIDUE SO4 B 7
16BC7SOFTWARELYS B:230 , ILE B:231 , HOH B:452BINDING SITE FOR RESIDUE SO4 B 8
17BC8SOFTWAREGLN B:69 , ASN B:72BINDING SITE FOR RESIDUE SO4 B 9
18BC9SOFTWAREILE B:130 , LYS B:132 , GLY B:133 , ARG B:134BINDING SITE FOR RESIDUE SO4 B 10

(-) SS Bonds  (16, 16)

Asymmetric Unit
No.Residues
1A:70 -A:96
2A:74 -A:84
3A:128 -A:206
4A:149 -A:189
5A:177 -A:201
6A:211 -A:288
7A:232 -A:271
8A:260 -A:283
9B:70 -B:96
10B:74 -B:84
11B:128 -B:206
12B:149 -B:189
13B:177 -B:201
14B:211 -B:288
15B:232 -B:271
16B:260 -B:283

(-) Cis Peptide Bonds  (4, 4)

Asymmetric Unit
No.Residues
1Ile A:156 -Pro A:157
2Thr A:239 -Pro A:240
3Ile B:156 -Pro B:157
4Thr B:239 -Pro B:240

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (1, 2)

Asymmetric Unit (1, 2)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_014570S153IHGF_HUMANPolymorphism17566A/BS153I

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (1, 2)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_014570S153IHGF_HUMANPolymorphism17566A/BS153I

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_014570S153IHGF_HUMANPolymorphism17566AS153I

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 3 (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_014570S153IHGF_HUMANPolymorphism17566BS153I

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (3, 10)

Asymmetric Unit (3, 10)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PANPS50948 PAN/Apple domain profile.HGF_HUMAN37-123
 
  2A:37-123
B:37-123
2KRINGLE_2PS50070 Kringle domain profile.HGF_HUMAN127-206
 
210-288
 
304-383
390-469
  4A:127-206
B:127-206
A:210-288
B:210-288
-
-
3KRINGLE_1PS00021 Kringle domain signature.HGF_HUMAN176-189
 
259-271
 
353-365
439-452
  4A:176-189
B:176-189
A:259-271
B:259-271
-
-
Biological Unit 1 (3, 10)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PANPS50948 PAN/Apple domain profile.HGF_HUMAN37-123
 
  2A:37-123
B:37-123
2KRINGLE_2PS50070 Kringle domain profile.HGF_HUMAN127-206
 
210-288
 
304-383
390-469
  4A:127-206
B:127-206
A:210-288
B:210-288
-
-
3KRINGLE_1PS00021 Kringle domain signature.HGF_HUMAN176-189
 
259-271
 
353-365
439-452
  4A:176-189
B:176-189
A:259-271
B:259-271
-
-
Biological Unit 2 (3, 5)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PANPS50948 PAN/Apple domain profile.HGF_HUMAN37-123
 
  1A:37-123
-
2KRINGLE_2PS50070 Kringle domain profile.HGF_HUMAN127-206
 
210-288
 
304-383
390-469
  2A:127-206
-
A:210-288
-
-
-
3KRINGLE_1PS00021 Kringle domain signature.HGF_HUMAN176-189
 
259-271
 
353-365
439-452
  2A:176-189
-
A:259-271
-
-
-
Biological Unit 3 (3, 5)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PANPS50948 PAN/Apple domain profile.HGF_HUMAN37-123
 
  1-
B:37-123
2KRINGLE_2PS50070 Kringle domain profile.HGF_HUMAN127-206
 
210-288
 
304-383
390-469
  2-
B:127-206
-
B:210-288
-
-
3KRINGLE_1PS00021 Kringle domain signature.HGF_HUMAN176-189
 
259-271
 
353-365
439-452
  2-
B:176-189
-
B:259-271
-
-

(-) Exons   (7, 14)

Asymmetric Unit (7, 14)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.2aENST000002223902aENSE00001949645chr7:81399514-81399200315HGF_HUMAN1-30300--
1.3bENST000002223903bENSE00000698746chr7:81392188-81392023166HGF_HUMAN30-85562A:35-85
B:34-85
51
52
1.4bENST000002223904bENSE00001790262chr7:81388120-81388008113HGF_HUMAN85-123392A:85-123
B:85-123
39
39
1.5bENST000002223905bENSE00000698725chr7:81386619-81386505115HGF_HUMAN123-161392A:123-161
B:123-161
39
39
1.6aENST000002223906aENSE00000698723chr7:81381578-81381436143HGF_HUMAN161-209492A:161-209
B:161-209
49
49
1.7ENST000002223907ENSE00000698721chr7:81374436-81374316121HGF_HUMAN209-249412A:209-249
B:209-249
41
41
1.8ENST000002223908ENSE00000698671chr7:81372787-81372669119HGF_HUMAN249-289412A:249-289
B:249-289
41
41
1.10ENST0000022239010ENSE00000698668chr7:81359095-81358921175HGF_HUMAN289-347592A:289-289
B:289-289
1
1
1.11ENST0000022239011ENSE00000698665chr7:81355333-81355206128HGF_HUMAN347-390440--
1.12ENST0000022239012ENSE00000698663chr7:81350163-81350061103HGF_HUMAN390-424350--
1.13ENST0000022239013ENSE00000698662chr7:81346681-81346548134HGF_HUMAN424-469460--
1.14ENST0000022239014ENSE00000698661chr7:81340835-8134079739HGF_HUMAN469-482140--
1.15ENST0000022239015ENSE00000698660chr7:81339559-8133946397HGF_HUMAN482-514330--
1.16ENST0000022239016ENSE00000698659chr7:81336680-8133660675HGF_HUMAN514-539260--
1.17ENST0000022239017ENSE00000698658chr7:81335743-81335603141HGF_HUMAN539-586480--
1.18ENST0000022239018ENSE00000698657chr7:81335069-81334963107HGF_HUMAN586-622370--
1.19ENST0000022239019ENSE00000698655chr7:81334851-81334706146HGF_HUMAN622-670490--
1.20bENST0000022239020bENSE00001870741chr7:81332073-813283223752HGF_HUMAN671-728580--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:255
 aligned with HGF_HUMAN | P14210 from UniProtKB/Swiss-Prot  Length:728

    Alignment length:255
                                    44        54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284     
            HGF_HUMAN    35 RRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGLMDHTESGKICQRWDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCAIKTCA 289
               SCOP domains d3sp8a1 A:35-126 Hepatocyte growth factor                                                   d3sp8a2 A:127-210 NK1 fragment of hepatocyte growth factor                          d3sp8a3 A:211-289 NK1 fragment of hepatocyte growth factor                      SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...hhh.eeee..eeeee.......eeee..hhhhhhhhhhh.........eeeee....eeeee........eeeee...eeeeeehhhhh.............................................................eee.......eee....hhhhhhee.........................................................eee.......eee...ee.. Sec.struct. author
                 SAPs(SNPs) ----------------------------------------------------------------------------------------------------------------------I---------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) --PAN  PDB: A:37-123 UniProt: 37-123                                                     ---KRINGLE_2  PDB: A:127-206 UniProt: 127-206                                      ---KRINGLE_2  PDB: A:210-288 UniProt: 210-288                                     - PROSITE (1)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------------------KRINGLE_1     ---------------------------------------------------------------------KRINGLE_1    ------------------ PROSITE (2)
           Transcript 1 (1) Exon 1.3b  PDB: A:35-85 UniProt: 30-85 [INCOMPLETE]-------------------------------------Exon 1.5b  PDB: A:123-161              -----------------------------------------------Exon 1.7  PDB: A:209-249 UniProt: 209-249---------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) --------------------------------------------------Exon 1.4b  PDB: A:85-123               -------------------------------------Exon 1.6a  PDB: A:161-209 UniProt: 161-209       ---------------------------------------Exon 1.8  PDB: A:249-289 UniProt: 249-289 Transcript 1 (2)
                 3sp8 A  35 RRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSDIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTSNGESYRGLMDHTESGKICQRWDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCKIKTCK 289
                                    44        54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284     

Chain B from PDB  Type:PROTEIN  Length:256
 aligned with HGF_HUMAN | P14210 from UniProtKB/Swiss-Prot  Length:728

    Alignment length:256
                                    43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283      
            HGF_HUMAN    34 KRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGLMDHTESGKICQRWDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCAIKTCA 289
               SCOP domains d3sp8b1 B:34-126 Hepatocyte growth factor                                                    d3sp8b2 B:127-210 NK1 fragment of hepatocyte growth factor                          d3sp8b3 B:211-289 NK1 fragment of hepatocyte growth factor                      SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....hhh.eeee..eeeee.......eeee..hhhhhhhhhhh.........eeeee....eeeee........eeeee...eeeeeehhhhh....................................hhhhh....................eee.......eee....hhhhhhee.................................hhhhh...................eee.......eee...ee.. Sec.struct. author
                 SAPs(SNPs) -----------------------------------------------------------------------------------------------------------------------I---------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) ---PAN  PDB: B:37-123 UniProt: 37-123                                                     ---KRINGLE_2  PDB: B:127-206 UniProt: 127-206                                      ---KRINGLE_2  PDB: B:210-288 UniProt: 210-288                                     - PROSITE (1)
                PROSITE (2) ----------------------------------------------------------------------------------------------------------------------------------------------KRINGLE_1     ---------------------------------------------------------------------KRINGLE_1    ------------------ PROSITE (2)
           Transcript 1 (1) Exon 1.3b  PDB: B:34-85 UniProt: 30-85 [INCOMPLETE] -------------------------------------Exon 1.5b  PDB: B:123-161              -----------------------------------------------Exon 1.7  PDB: B:209-249 UniProt: 209-249---------------------------------------1 Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------Exon 1.4b  PDB: B:85-123               -------------------------------------Exon 1.6a  PDB: B:161-209 UniProt: 161-209       ---------------------------------------Exon 1.8  PDB: B:249-289 UniProt: 249-289 Transcript 1 (2)
                 3sp8 B  34 KRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSDIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTSNGESYRGLMDHTESGKICQRWDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCKIKTCK 289
                                    43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283      

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 6)

Asymmetric Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 3SP8)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 3SP8)

(-) Gene Ontology  (47, 47)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (HGF_HUMAN | P14210)
molecular function
    GO:0042056    chemoattractant activity    Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
    GO:0008083    growth factor activity    The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0046982    protein heterodimerization activity    Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
    GO:0004252    serine-type endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
    GO:0000187    activation of MAPK activity    The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
    GO:0031100    animal organ regeneration    The regrowth of a lost or destroyed animal organ.
    GO:0060326    cell chemotaxis    The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
    GO:0000902    cell morphogenesis    The developmental process in which the size or shape of a cell is generated and organized.
    GO:0008283    cell proliferation    The multiplication or reproduction of cells, resulting in the expansion of a cell population.
    GO:0035729    cellular response to hepatocyte growth factor stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hepatocyte growth factor stimulus.
    GO:0001837    epithelial to mesenchymal transition    A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
    GO:0048012    hepatocyte growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of the hepatocyte growth factor receptor binding to one of its physiological ligands.
    GO:0030212    hyaluronan metabolic process    The chemical reactions and pathways involving hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
    GO:0001889    liver development    The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
    GO:0051450    myoblast proliferation    The multiplication or reproduction of myoblasts, resulting in the expansion of a myoblast cell population. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:0010507    negative regulation of autophagy    Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
    GO:0043154    negative regulation of cysteine-type endopeptidase activity involved in apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
    GO:1902042    negative regulation of extrinsic apoptotic signaling pathway via death domain receptors    Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
    GO:1901299    negative regulation of hydrogen peroxide-mediated programmed cell death    Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death.
    GO:0050728    negative regulation of inflammatory response    Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
    GO:0032715    negative regulation of interleukin-6 production    Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
    GO:0033137    negative regulation of peptidyl-serine phosphorylation    Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine.
    GO:0090201    negative regulation of release of cytochrome c from mitochondria    Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
    GO:0002576    platelet degranulation    The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
    GO:0050918    positive chemotaxis    The directed movement of a motile cell or organism towards a higher concentration of a chemical.
    GO:2000573    positive regulation of DNA biosynthetic process    Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
    GO:0045766    positive regulation of angiogenesis    Any process that activates or increases angiogenesis.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0032733    positive regulation of interleukin-10 production    Any process that activates or increases the frequency, rate, or extent of interleukin-10 production.
    GO:0031643    positive regulation of myelination    Any process that activates or increases the frequency, rate or extent of the formation of a myelin sheath around nerve axons.
    GO:0070572    positive regulation of neuron projection regeneration    Any process that activates or increases the frequency, rate or extent of neuron projection regeneration, the regrowth of neuronal processes such as axons or dendrites following their loss or damage.
    GO:0045669    positive regulation of osteoblast differentiation    Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
    GO:0050731    positive regulation of peptidyl-tyrosine phosphorylation    Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
    GO:0014068    positive regulation of phosphatidylinositol 3-kinase signaling    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0060665    regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling    Any process that modulates the rate, frequency, or extent of branching involved in salivary gland morphogenesis as a result of signals being generated by the mesenchyme and received and interpreted by the salivary gland epithelium.
    GO:1900744    regulation of p38MAPK cascade    Any process that modulates the frequency, rate or extent of p38MAPK cascade.
    GO:1902947    regulation of tau-protein kinase activity    Any process that modulates the frequency, rate or extent of tau-protein kinase activity.
cellular component
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0031093    platelet alpha granule lumen    The volume enclosed by the membrane of the platelet alpha granule.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    MES  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    MPD  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    MRD  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    SO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC7  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    BC9  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Ile A:156 - Pro A:157   [ RasMol ]  
    Ile B:156 - Pro B:157   [ RasMol ]  
    Thr A:239 - Pro A:240   [ RasMol ]  
    Thr B:239 - Pro B:240   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]
    Biological Unit 3  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3sp8
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  HGF_HUMAN | P14210
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  HGF_HUMAN | P14210
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        HGF_HUMAN | P142101bht 1gmn 1gmo 1gp9 1nk1 1shy 1si5 2ced 2cee 2ceg 2hgf 2qj2 3hms 3hmt 3hn4 3mkp 4d3c 4k3j 4o3t 4o3u 5coe 5cp9 5cs1 5cs3 5cs5 5cs9 5csq 5ct1 5ct2 5ct3

(-) Related Entries Specified in the PDB File

1gmn NK1 IN COMPLEX WITH HEPARIN
1gp9 NK1
2ouh THROMBOSPONDIN-1 N-TERMINAL DOMAIN IN COMPLEX WITH FRACTIONATED HEPARIN DP10
3hn4 NK2 STRUCTURE
3mkp NK1 IN COMPLEX WITH HEPARIN